Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Leukemia, Myeloid, Acute 61Leukemia 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Myelomonocytic, Acute 33Leukemia, Monocytic, Acute 29Congenital Abnormalities 28Leukemia, Erythroblastic, Acute 26Leukemia, Megakaryoblastic, Acute 25Lymphoma 24Myelodysplastic Syndromes 18Burkitt Lymphoma 16Leukemia, Myelomonocytic, Chronic 13Anemia, Refractory, with Excess of Blasts 13Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Myeloproliferative Disorders 11Leukemia, Eosinophilic, Acute 11Leukemia, Basophilic, Acute 11Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Follicular 8Blast Crisis 8Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Lymphoma, Mantle-Cell 6Leukemia, Promyelocytic, Acute 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5

Interventions

Temozolomide 17Bevacizumab 10Radiotherapy 9Carmustine 9Magnetic Resonance Spectroscopy 7Erlotinib Hydrochloride 7Carboplatin 7Sorafenib 6Lapatinib 6Chemotherapy, Adjuvant 62,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 6temsirolimus 5Vorinostat 5Surgical Procedures, Operative 5Sirolimus 5Radiosurgery 5Radiation 5Dexamethasone 5cediranib 4Immunoglobulin G 4Disulfides 4Cyclophosphamide 4Cilengitide 4pazopanib 3Thalidomide 3Procarbazine 3Nivolumab 3Neoadjuvant Therapy 3Irinotecan 3Iodine-125 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Brain Neoplasms × Cytarabine × Clear all
NCT00000801 2012-11-01

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
33 enrolled
CNSLymphoid

Acquired Immunodeficiency Syndrome, Brain Neoplasms, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡